2022 Psychiatry

Symposium

A Hybrid Event

 


November 5, 2022
Renaissance Hotel - Newport Beach, CA

 

LEARNING OBJECTIVES


At the end of this activity, learners will be able to:

  • Screening & Diagnosis: Improve screening and accurate diagnosis of ADHD, autism, behavioral addition, bipolar with comorbidities
  • Treatment: Effectively utilize current evidence-based treatment to improve outcomes for: ADHD across the lifespan, teens in crisis, behavioral addictions, PASC, and/or bipolar disease with comorbidities
  • Communication: Apply practical tips in discussions with patients regarding ADHD in context of cannabis or pandemic-related changes, autism dx, tx for teens in crisis, management options for PASC, and/or addressing difficult behaviors that may affect adherence
  • Nutritional approaches: Explore and educate patients on current evidence-based approaches to nutrition and its impact on our brain and wellbeing


ACCREDITATION

AMA PRA Category 1 Credit™
The Southern California Permanente Medical Group is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

The Southern California Permanente Medical Group designates this live educational activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Board of Psychiatry and Neurology has reviewed the 2022 SCPMG Psychiatry HYBRID Symposium and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

Nurses and Physician Assistants – Attendees may report up to 6.0 hours toward continuing education requirements for license renewal. ‘CME’ can be written in lieu of the provider number on all licensure renewal applications

THERAPISTS
This training has been approved for 6 CE units for California LCSWs and LMFTs upon completion of the entire training.

PSYCHOLOGISTS
Kaiser Permanente is approved by the California Psychological Association to provide continuing professional education for psychologists. This training has been approved for 6 CE units upon completion of the entire training. Kaiser Permanente maintains responsibility for this program and its content.

TARGET AUDIENCE

Primary Target Group:
SCPMG Psychiatrists (Adult Psychiatry, Child Psychiatry, and Addiction Medicine), Psychologists, and KP SCAL Therapists

Secondary Target Group:
Family Medicine & Internal Medicine physicians; Nurse Practitioners and Physician Assistants in Psychiatry, Depression Care Management; residents, medical students

Regions: All